Identification of novel autoantibodies to GABAB receptors in patients with neuropsychiatric systemic lupus erythematosus

Rheumatology (United Kingdom)

Volumn 53, Issue 7, 2014, Pages 1219-1228

  Tsuchiya, Haruka ^a   Haga, Shiori ^a   Takahashi, Yuko ^a   Kano, Toshikazu ^a   Ishizaka, Yukihito ^a   Mimori, Akio ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Autoantibody; Disease activity; Neuropsychiatric systemic lupus erythematosus; Systemic lupus erythematosus

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AUTOANTIBODY; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; RECOMBINANT PROTEIN; RO ANTIBODY; SM ANTIBODY; STEROID;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; APHASIA; ARTHRITIS; ARTICLE; ASEPTIC MENINGITIS; BLOOD CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR DISEASE; CHOREA; CHRONIC PATIENT; CLINICAL FEATURE; CONFUSION; CONTROLLED STUDY; CRANIAL NEUROPATHY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FEMALE; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENTAL DISEASE; MONONEUROPATHY; MOTOR DYSFUNCTION; MYELITIS; MYOSITIS; NEPHRITIS; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SCLERODERMA; SEIZURE; SLEDAI; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; VASCULITIS; VISUAL FIELD DEFECT;

AUTOANTIBODY; DISEASE ACTIVITY; GABAB RECEPTOR; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MIDDLE AGED; RECEPTORS, GABA-B; SEVERITY OF ILLNESS INDEX;

EID: 84902977347     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket481     Document Type: Article

References (44)

1. Hahn BH. An overview of the pathogenesis of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. Philadelphia: Williams and Wilkins, 1993:69-76.
2. Winchester RJ. Systemic lupus erythematosus pathogenesis. In: Koopman W, ed. Arthritis and Allied Conditions. Philadelphia: Williams and Wilkins, 1996:1361-91.
3. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349: 1526-33.
4. Edworthy S. Clinical manifestations of systemic lupus erythematosus. In: Harris ED, Budd RC, Firestein GS, eds. Kelly's Textbook of Rheumatology. Philadelphia: Elsevier Saunders, 2004:1204-15.
5. Ainiala H, Loukkola J, Peltola J et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001;57:496-500.
6. Sanna G, Bertolaccini ML, Cuadrado MJ et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30: 985-92.
7. Loukkola J, Laine M, Ainiala H et al. Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study. J Clin Exp Neuropsychol 2003; 25:145-51.
8. Reichlin M. Ribosomal P antibodies and CNS lupus. Lupus 2003;12:916-8.
9. Kurki P, Helve T, Dahl D et al. Neurofilament antibodies in systemic lupus erythematosus. J Rheumatol 1986;13: 69-73.
10. Williams RC Jr, Sugiura K, Tan EM. Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2004;50:1239-47.
11. Enna SJ, Bowery NG. GABA(B) receptor alterations as indicators of physiological and pharmacological function. Biochem Pharmacol 2004;68:1541-8.
12. Emson PC. GABA(B) receptors: structure and function. Prog Brain Res 2007;160:43-57.
13. Ladera C, del Carmen Godino M, Jose Cabanero M et al. Pre-synaptic GABA receptors inhibit glutamate release through GIRK channels in rat cerebral cortex. J Neurochem 2008;107:1506-17.
14. Kaneda K, Tachibana Y, Imanishi M et al. Down-regulation of metabotropic glutamate receptor 1a in globus pallidus and substantia nigra of parkinsonian monkeys. Eur J Neurosci 2005;22:3241-54.
15. Nicoll RA. My close encounter with GABA(B) receptors. Biochem Pharmacol 2004;68:1667-74.
16. Kaneda K, Kita H. Synaptically released GABA activates both pre-and postsynaptic GABA(B) receptors in the rat globus pallidus. J Neurophysiol 2005;94:1104-14.
17. Mann EO, Kohl MM, Paulsen O. Distinct roles of GABA(A) and GABA(B) receptors in balancing and terminating persistent cortical activity. J Neurosci 2009;29:7513-8.
18. Brown JT, Davies CH, Randall AD. Synaptic activation of GABA(B) receptors regulates neuronal network activity and entrainment. Eur J Neurosci 2007;25:2982-90.
19. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Bombardier C, Gladman DD, Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
21. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15: 241-50.
22. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521-30.
23. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
24. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
25. Takahashi Y, Haga S, Ishizaka Y et al. Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Res Ther 2010;12: R85.
26. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990;33:1065-144.
27. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
28. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
29. Lefkowith JB, Kiehl M, Rubenstein J et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J Clin Invest 1996;15: 1373-80.
30. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257: 509-17.
31. Lancaster E, Lai M, Peng X et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76.
32. Duthey B, Hübner A, Diehl S et al. Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis. Exp Dermatol 2010;19:661-6.
33. Jin Z, Mendu SK, Birnir B. GABA is an effective immunomodulatory molecule. Amino Acids 2013;45: 87-94.
34. Winfield JB, Shaw M, Silverman LM et al. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 1983;74:837-44.
35. McLean BN, Miller D, Thompson EJ. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system. J Neurol Neurosurg Psychiatry 1995;58: 548-54.
36. Abbott NJ, Mendonca LL, Dolman DE. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003;12: 908-1.
37. Hirohata S, Hirose S, Miyamoto T. Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus: their use as estimates of central nervous system disease activity. Arch Intern Med 1985;145: 1843-6.
38. Dellalibera-Joviliano R, Dos Reis ML, Cunha Fde Q et al. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus. J Rheumatol 2003; 30:485-92.
39. Trysberg E, Carlsten H, Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 2000;9:498-503.
40. Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007;56:1242-50.
41. Arnett FC, Reveille JD, Moutsopoulos HM et al. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum 1996;39: 1833-9.
42. Karassa FB, Afeltra A, Ambrozic A et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006;54: 312-24.
43. DeGiorgio LA, Konstantinov KN, Lee SC et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93.
44. Kowal C, DeGiorgio LA, Nakaoka T et al. Cognition and immunity; antibody impairs memory. Immunity 2004;21: 179-88.